As of 31 Dec 2025, 1 institutional investors reported holding 500 shares of ELITE PHARMACEUTICALS INC /NV/ - COM (ELTP).
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 500 | $245 | -$3,317 | $0.49 | 1 |
| 2025 Q3 | 5,682 | $3,637 | +$320 | $0.64 | 2 |
| 2025 Q2 | 5,182 | $3,793 | $0.73 | 1 | |
| 2025 Q1 | 5,182 | $2,254 | +$2,254 | $0.44 | 1 |
| 2023 Q4 | 0 | $0 | -$7,693 | $0.49 | 0 |
| 2023 Q3 | 82,000 | $7,693 | +$7,693 | $0.09 | 1 |
| 2023 Q2 | 0 | $0 | -$2,378 | $0.49 | 0 |
| 2023 Q1 | 82,000 | $2,378 | +$2,378 | $0.03 | 1 |
| 2022 Q4 | 0 | $0 | -$24,000 | $0.49 | 0 |
| 2022 Q3 | 659,605 | $24,000 | $0.04 | 2 | |
| 2022 Q2 | 659,605 | $29,000 | +$10,314 | $0.05 | 2 |
| 2022 Q1 | 622,122 | $39,000 | -$8,545 | $0.04 | 3 |
| 2021 Q4 | 814,605 | $28,000 | +$3,000 | $0.04 | 3 |
| 2021 Q3 | 200,000 | $9,000 | -$2,000 | $0.04 | 1 |
| 2021 Q2 | 248,778 | $12,000 | $0.05 | 2 | |
| 2021 Q1 | 248,778 | $15,000 | $0.06 | 2 | |
| 2020 Q4 | 248,778 | $13,000 | +$10,000 | $0.06 | 2 |
| 2020 Q3 | 48,778 | $3,000 | $0.06 | 1 | |
| 2020 Q2 | 48,778 | $4,000 | $0 | $0.08 | 1 |
| 2020 Q1 | 50,000 | $4,000 | $0.08 | 1 | |
| 2019 Q4 | 50,000 | $5,000 | -$9,142 | $0.10 | 1 |
| 2019 Q3 | 158,778 | $13,142 | +$4,000 | $0.08 | 3 |
| 2019 Q2 | 110,000 | $4,640 | -$5,000 | $0.04 | 2 |
| 2019 Q1 | 160,000 | $15,940 | +$5,000 | $0.10 | 3 |
| 2018 Q4 | 110,000 | $8,494 | $0.08 | 2 | |
| 2018 Q3 | 110,000 | $10,400 | $0.10 | 2 | |
| 2018 Q2 | 110,000 | $10,400 | +$5,000 | $0.10 | 2 |
| 2018 Q1 | 60,000 | $6,000 | $0.10 | 1 | |
| 2017 Q4 | 60,000 | $5,520 | -$4,000 | $0.09 | 1 |
| 2017 Q3 | 100,000 | $10,060 | $0.10 | 2 | |
| 2017 Q2 | 501,252 | $94,280 | +$9,008 | $0.19 | 3 |
| 2017 Q1 | 453,060 | $66,874 | +$8,819 | $0.15 | 3 |
| 2016 Q4 | 393,180 | $60,120 | -$5,000 | $0.15 | 3 |
| 2016 Q3 | 425,680 | $74,560 | $0.18 | 5 | |
| 2016 Q2 | 425,680 | $137,500 | +$2,000 | $0.32 | 5 |
| 2016 Q1 | 418,180 | $129,600 | -$1,000 | $0.31 | 4 |
| 2015 Q4 | 380,680 | $155,540 | -$12,059 | $0.40 | 4 |
| 2015 Q3 | 438,380 | $100,800 | -$9,000 | $0.23 | 5 |
| 2015 Q2 | 488,380 | $98,000 | $0.20 | 5 | |
| 2015 Q1 | 488,380 | $119,700 | -$5,000 | $0.24 | 5 |
| 2014 Q4 | 510,880 | $115,560 | -$590 | $0.23 | 5 |
| 2014 Q3 | 455,880 | $145,362 | +$12,341 | $0.32 | 4 |
| 2014 Q2 | 415,430 | $176,375 | $0.42 | 3 | |
| 2014 Q1 | 415,430 | $170,283 | +$43,237 | $0.41 | 3 |